Cyclodiode laser is an effective alternative to lensectomy in acute angle closure

Article

Using a cyclodiode laser to manage acute angle closure is a safe and effective alternative to emergency lensectomy or trabeculectomy

Using a cyclodiode laser to manage acute angle closure is a safe and effective alternative to emergency lensectomy or trabeculectomy, claims a study in the journal Eye.

Dr A. Manna et al., Birmingham Midland Eye Centre, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK, conducted a retrospective case series on five patients with acute angle closure refractory to medical and laser treatment.

All participants underwent cyclodiode laser treatment. The team recorded each patient's demographic information, symptoms, medical and surgical treatment, visual outcomes and intraocular pressure (IOP).

Sufficient IOP control was not achieved with conventional management such as topical and systemic medical treatment, laser iridotomy and laser iridoplasty. Within 2 to 23 days of presentation of acute angle closure, emergency cyclodiode laser treatment was completed.

Lensectomy was performed in all patients at a later date, with final visual acuity of 6/12 or better with well-maintained IOPs. Just one patient required topical treatment and one patient developed persistent low-grade anterior uveitis.

Cyclodiode laser treatment is a successful alternative to managing acute angle closure for patients who do not respond to other treatments.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.